Results 191 to 200 of about 420,257 (333)

Global, regional and national burden of blindness and vision loss attributable to diabetic retinopathy, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Diabetes is increasingly reported as a cause of blindness and vision loss. However, the trends in the burden of blindness and vision loss attributed to diabetic retinopathy (DR) have yet to be fully elucidated. Materials and Methods Utilizing the latest data from the Global Burden of Disease Study 2021, we extracted prevalence and years ...
Yujie Pan   +4 more
wiley   +1 more source

Triamcinolona subtenoniana en el edema macular diabético Subtenon triamcinolone in the diabetic macular edema

open access: yesRevista Cubana de Oftalmología, 2009
INTRODUCCIÓN: La prevalencia de la retinopatía diabética está determinada por el tipo de diabetes mellitus y por el tiempo de evolución de la enfermedad.
Eddy Mesa Hernández   +4 more
doaj  

A Phase II Randomized Clinical Trial of Intravitreal Bevacizumab for Diabetic Macular Edema [PDF]

open access: green, 2007
Ingrid U. Scott   +12 more
openalex   +1 more source

Systemic, Lifestyle and Environmental Modifying Factors in the Pathogenesis of Periodontitis

open access: yesJournal of Periodontal Research, EarlyView.
A variety of impacting factors in the pathogenesis of periodontitis exist, including systemic, lifestyle, and environmental factors. This review highlights the manifold mechanistic aspects of the link between the pathogenesis of periodontitis, addressing these numerous factors to supplement the long‐standing knowledge of the progression of the disease.
Groeger Sabine Elisabeth   +5 more
wiley   +1 more source

Primary Intravitreal Bevacizumab (Avastin) for Diabetic Macular Edema [PDF]

open access: bronze, 2007
J. Fernando Arévalo   +8 more
openalex   +1 more source

Artificial intelligence for age‐related macular degeneration diagnosis in Australia: A Novel Qualitative Interview Study

open access: yesOphthalmic and Physiological Optics, EarlyView.
Abstract Introduction Artificial intelligence (AI) systems for age‐related macular degeneration (AMD) diagnosis abound but are not yet widely implemented. AI implementation is complex, requiring the involvement of multiple, diverse stakeholders including technology developers, clinicians, patients, health networks, public hospitals, private providers ...
Angelica Ly   +3 more
wiley   +1 more source

High risk does not guarantee high accuracy—Evaluating the prognostic accuracy of OCT biomarkers for predicting late AMD

open access: yesOphthalmic and Physiological Optics, EarlyView.
Abstract Purpose The translation of high‐risk biomarkers into accurate predictions of late age‐related macular degeneration (AMD) may be limited by biomarker prevalence, subjective identification and competing risks from concurrent biomarkers. This study evaluates the prognostic performance of key optical coherence tomography (OCT) biomarkers for ...
Matt Trinh   +5 more
wiley   +1 more source

Intravitreal Injection of Triamcinolone for Diffuse Diabetic Macular Edema

open access: bronze, 2003
Jost B. Jonas   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy